Bank of New York Mellon »

Theravance Biopharma shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 162k 8.97
2023-12-31 $2.2M 196k 11.24
2023-09-30 $1.8M 203k 8.63
2023-06-30 $2.2M 216k 10.35
2023-03-31 $2.3M 210k 10.85
2022-12-31 $2.4M 212k 11.22
2022-09-30 $2.1M 206k 10.14
2022-06-30 $1.6M 182k 9.07
2022-03-31 $1.8M 190k 9.56
2021-12-31 $2.0M 188k 10.53
2021-09-30 $1.3M 176k 7.41
2021-06-30 $2.5M 175k 14.53
2021-03-31 $4.1M 202k 20.41
2020-12-31 $3.7M 206k 17.78
2020-09-30 $3.1M 211k 14.78
2020-06-30 $4.5M 215k 20.96
2020-03-31 $4.9M 211k 23.11
2019-12-31 $5.3M 203k 25.90
2019-09-30 $3.8M 197k 19.48
2019-06-30 $3.4M 208k 16.34
2019-03-31 $4.7M 209k 22.68
2018-12-31 $5.3M 208k 25.59
2018-09-30 $6.7M 206k 32.67
2018-06-30 $4.7M 206k 22.68
2018-03-31 $5.1M 210k 24.25
2017-12-31 $5.9M 211k 27.88
2017-06-30 $8.3M 208k 39.83
2017-03-31 $7.6M 206k 36.81
2016-12-31 $6.4M 201k 31.88
2016-09-30 $8.0M 222k 36.24
2016-06-30 $4.1M 180k 22.70